Molecular predictive and prognostic markers in colon cancer.
about
Evolving Therapies and FAK Inhibitors for the Treatment of CancerPharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsThe proteomics of colorectal cancer: identification of a protein signature associated with prognosis.Methylated DNA as Promising Marker for Early Diagnosis of CancerDetection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditionsChallenges in the management of stage II colon cancerMolecular events in primary and metastatic colorectal carcinoma: a review.The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course.Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statementPredictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy.ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan.KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting.Genomics and pharmacogenomics of pancreatic adenocarcinoma.Diagnostic and prognostic molecular biomarkers for prostate cancer.Impact of the UGT1A1*28 allele on response to irinotecan: a systematic review and meta-analysis.VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update.The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis.Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.Lycopene Consumption and Risk of Colorectal Cancer: A Meta-Analysis of Observational Studies.Association between the expression levels of TAZ, AXL and CTGF and clinicopathological parameters in patients with colon cancer.Identification of responders/non-responders to 5-fluorouracil based on individual 50% inhibitory area under the concentration curve of 5-fluorouracil obtained with collagen gel droplet-embedded culture-drug sensitivity test in colorectal cancer.Cetuximab related eyelash elongations for patients with metastatic rectum carcinoma: metabolic complete response.Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth Conditions.The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients.Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor-associated antigen.Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population.
P2860
Q28972291-A6624E37-ADF5-4F7B-BB09-0D3AAA3EDE87Q34008793-BD22ABCD-7965-41DA-A3C8-35258D3F17EAQ34085776-6CAE4B03-C93E-4EFE-AE16-CC1C36EE688BQ34539679-D74D2281-A489-4276-99B7-B59B1DA6A8F5Q34565052-2B414182-9897-4BDC-AFD0-DC719643CDFBQ35622839-896A0D28-617B-4050-A2D2-768C6CD751F4Q35977849-C76BB376-5208-4FDD-BBA9-268FBE10FA8CQ36236179-5CE8807D-E7CB-4222-959B-B77531C545ABQ37037106-CF4C8BE9-D7D5-4F25-839D-BCA84B3DB24FQ37132742-DAA220D7-AD0E-4EF1-B828-8E12F9695176Q37287637-C3354549-C0DB-4D24-A997-C6C5ABCDA3BCQ37495964-E5C820BD-E9DF-4622-B87D-47A29B7AA1E2Q37970279-8909CFAF-CEB5-41F9-8922-ACDBC94702FFQ37972703-BB401266-9F85-4C62-8726-78D6BCAB4954Q38016943-55D90BC7-8B5D-4370-B639-64E6557B9043Q38148602-2C6D4F27-BE3F-41F0-9FBF-E32F1B9603BDQ38202816-FC75C164-FC28-4F84-9D7C-A7CFB84037FFQ38402754-90EEFB00-62D4-4618-91AD-5C6A4EEA113AQ38912448-FBCE8FA0-74A2-4213-AAC9-E822726F77BBQ39985108-00AB7666-37CC-4413-922C-1912E17C6AD6Q42007876-36967B00-CEB1-4624-AE88-848EE59A8F1FQ42181937-23E75CD6-3F83-4C85-B5C6-DF14CA65D1CFQ42353390-1EB815CD-ECEF-4AA3-8A93-11D6DAB27C4AQ45983305-84246874-A2E3-4419-B8C1-196CCCFC871BQ47109441-7BCE1FD8-D764-40A2-B689-E48D1CA59E5BQ47396804-28AFF5FA-8D28-419E-A32B-FB993B0D9644Q54224805-FCC1CB25-87B3-4927-92F6-B64CC83EC13A
P2860
Molecular predictive and prognostic markers in colon cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular predictive and prognostic markers in colon cancer.
@en
Molecular predictive and prognostic markers in colon cancer.
@nl
type
label
Molecular predictive and prognostic markers in colon cancer.
@en
Molecular predictive and prognostic markers in colon cancer.
@nl
prefLabel
Molecular predictive and prognostic markers in colon cancer.
@en
Molecular predictive and prognostic markers in colon cancer.
@nl
P1476
Molecular predictive and prognostic markers in colon cancer.
@en
P2093
Thomas Winder
P304
P356
10.1016/J.CTRV.2010.03.005
P577
2010-04-03T00:00:00Z